The diabetes tech landscape is changing fast, and one of the most exciting developments is the rise of non invasive glucose monitoring. If you haven’t heard of the Biolinq Shine yet, this new technology just made FDA history. The FDA granted Biolinq Shine de novo  classification, officially recognizing it as a new category of glucose sensor. Unlike traditional continuous glucose monitors (CGMs) that use a filament under the skin, this patch-style biosensor uses an array that measures glucose...

If the phrase “newest diabetes technology” has you rolling your eyes because, let’s face it, it usually means “a slightly different...

Living with diabetes can feel overwhelming, especially regarding managing your diet and lifestyle. Fortunately, various professionals are...